Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart

Journal of the American College of Cardiology

Volumn 40, Issue 8, 2002, Pages 1459-1465

  Leineweber, Kirsten ^a   Wangemann, Thekla ^b   Giessler, Christine ^a   Bruck, Heike ^a   Dhein, Stefan ^c   Kostelka, Martin ^c   Mohr, Friedrich Wilhelm ^c   Silber, Rolf Edgar ^b   Brodde, Otto Erich ^a,d,e  

^a Pop Monitoring U Martin Luther U   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^d UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DESIPRAMINE; NISOXETINE; NORADRENALIN; NORADRENALIN REUPTAKE TRANSPORTER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HEART; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; INFANT; INOTROPISM; MALE; NORADRENALIN UPTAKE; OPEN HEART SURGERY; PRIORITY JOURNAL;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGE FACTORS; AGED; AGING; ATRIAL FUNCTION; CHILD; CHILD, PRESCHOOL; DESIPRAMINE; HEART ATRIA; HUMANS; INFANT; MIDDLE AGED; NEURONS; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA;

EID: 0037120971     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02168-X     Document Type: Article

References (35)

1. Docherty JR. Cardiovascular responses in ageing: a review. Pharmacol Rev 1990;42:103-25.
2. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-67.
3. Brodde O-E, Michel MC. Adrenergic and muscarinergic receptors in the human heart. Pharmacol Rev 1999;51:651-89.
4. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature (Lond) 1976;261:333-5.
5. Esler MD, Jennings GL, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990;70:963-85.
6. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev 1993;73:725-64.
7. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1988;5:86-99.
8. Mörlin C, Wallin BG, Eriksson BM. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive men. Acta Physiol Scand 1983;119:117-21.
9. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993;21:498-503.
10. Graefe KH, Bönisch H. The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurons. In: Trendelenburg U, Weiner N, editors. Catecholamines I. Berlin: Springer-Verlag, 1988:193-245.
11. Trendelenburg U. Functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol Sci 1991;12:334-7.
12. Esler MD, Turner AG, Kaye DM, et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995;268:R278-85.
13. 1) in right ventricles of monocrotaline-treated rats. Br J Pharmacol 2000;131:1438-44.
14. Brodde O-E, Zerkowski H-R, Schranz D, et al. Age-dependent changes in the beta-adrenoceptor-G protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 1995;26:20-6.
15. Brodde O-E, Konschak U, Becker K, et al. Cardiac muscarinic receptors decrease with age: in vitro and in vivo studies. J Clin Invest 1998;101:471-8.
16. s-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 1998;31:585-94.
17. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the prinziple of protein-dye binding. Anal Biochem 1976;72:248-54.
18. Goldstein DS, Lake CF, Chernow B, et al. Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 1983;5:100-4.
19. Folkow B, DiBona GF, Hjemdahl P, Toren PH, Wallin BG. Measurements of plasma norepinephrine concentrations in human primary hypertension. Hypertension 1983;5:399-403.
20. Esler M, Skews H, Leonard P, Jackman G, Bobik A, Korner P. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci 1981;60:217-9.
21. Martinez JL, Vasquez BJ, Messing RB, Jensen RA, Liang KC, McGaugh JL. Age-related changes in catecholamine content of peripheral organs in male and female FJ44 rats. J Gerontol 1981;36:280-4.
22. Dawson R, Meldrum MJ. Norepinephrine content in cardiovascular tissue from aged Fischer 344 rats. Gerontology 1992;38:185-91.
23. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991;68:1560-8.
24. Gibson GE, Peterson C. Calcium and the aging nervous system. Neurobiol Aging 1987;8:329-43.
25. Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart: relationship with heart failure. Aging Clin Exp Res 1997;9:391-403.
26. Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Pool-Wison PA. Isolated ventricular myocytes from failing and non-failing human heart: the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 1992;24:549-64.
27. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994;90:1225-38.
28. Davies CH, Ferrara N, Harding SE. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res 1996;31:152-6.
29. 3H-isoproterenol in the rat. Biochem Pharmacol 1964;13:585-94.
30. Callingham BA, Burgen ASV. The uptake of isoprenaline and noradrenaline by the perfused rat heart. Mol Pharmacol 1966;2:37-42.
31. White M, Leenen FHH. Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. Clin Pharmacol Ther 1994;56:543-53.
32. White M, Leenen FHH. Effects of age on cardiovascular responses to adrenaline in man. Br J Clin Pharmacol 1997;43:407-14.
33. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22 Suppl A:61-71A.
34. Böhm M, LaRosee K, Schwinger RHG, Erdmann E. Evidence for reduction of noradrenaline uptake sites in the failing human heart. J Am Coll Cardiol 1995;25:146-53.
35. Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996;93:1667-76.